Latest Strategy News

Mammoth Minerals has significantly expanded the high-grade Blue Dick Trend at its Excelsior Gold-Silver Project in Nevada, reporting outstanding silver, gold, copper, and antimony results from recent sampling.

Macquarie Group Limited has announced a quarterly distribution of AUD 1.5799 per security on its perpetual capital notes, reflecting a steady income stream with partial franking. The payment is scheduled for December 12, 2025.

Light & Wonder, Inc. is set to extend its substantial share repurchase program to include its ASX-listed CHESS Depositary Interests starting November 7, 2025, coinciding with its planned Nasdaq delisting.

AVITA Medical reported an 18% revenue increase in Q3 2025 driven by new product launches and deeper market penetration, while continuing to face net losses and credit covenant challenges. The company also announced a CEO departure and interim leadership appointment.

AVITA Medical reported a 13% drop in Q3 commercial revenue to $17.1 million but improved its net loss and secured CE Mark approval for RECELL GO in Europe, signaling strategic shifts ahead.

Aurum Resources reports strong high-grade gold intercepts from its extensive drilling program at the Boundiali Gold Project in Côte d’Ivoire, boosting resource confidence ahead of major updates in early 2026.

Tanami Gold NL has updated its Central Tanami Project Mineral Resource Estimate, boosting total gold resources to 2.8 million ounces. This increase reflects recent drilling, higher gold price assumptions, and improved metallurgical recoveries across multiple deposits.

Indiana Resources has reported strong assay results confirming the continuation of high-grade gold mineralisation at depth within its Minos Gold Project in South Australia, alongside significant silver mineralisation. The company is advancing a 7,000m air-core drilling program at nearby prospects, supporting its hub and spoke development strategy.

Macquarie Group Limited reported a 3% increase in net profit to A$1.655 billion for the half year ended 30 September 2025, driven by robust performances in its asset management and capital segments. The Group’s diversified funding and strong capital position underpin its strategic growth and climate finance initiatives.

Macquarie Group Limited reported a 3% increase in half-year profit to $1.655 billion, driven by growth across its asset management, banking, commodities, and capital markets divisions. The group maintains robust capital and liquidity positions despite margin pressures and regulatory challenges.

MedAdvisor Limited has appointed John Ciccio as its new CEO and Managing Director, marking a strategic leadership shift aimed at capitalising on recent technology advancements and US market growth.

Macquarie Group Limited has announced an ordinary dividend of AUD 2.80 per share for the half-year ending September 2025, accompanied by a fully franked component and a Dividend Reinvestment Plan available to shareholders.